FUBO vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

FUBO

52.7
AI Score
VS
FUBO Wins

CLOV

48.9
AI Score

Investment Advisor Scores

FUBO

53score
Recommendation
HOLD

CLOV

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FUBO CLOV Winner
Forward P/E 52.6316 81.9672 FUBO
PEG Ratio 0 0 Tie
Revenue Growth 39.8% 62.0% CLOV
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 52.7/100 48.9/100 FUBO
Profit Margin -1.6% -2.6% FUBO
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

FUBO 1M: -12.2% · 3M: -28.2% CLOV 1M: -22.6% · 3M: +51.6%

Current Technical Phase

FUBO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.1 · Price: $8.85

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.3 · Price: $4.17

Fundamentals Snapshot

Metric FUBO CLOV
Market Cap
Forward P/E 18.8 41.7
Trailing P/E 2.3
Revenue (TTM)
Revenue Growth 0.4% 0.6%
Gross Margin 0.0% 0.2%
Operating Margin 0.0% 0.0%
EPS 3.73 -0.12
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, FUBO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.